Views & Analysis The art of storytelling in clinical data communication − wha... What can we learn from Batman and the Joker, the greatest hero/villain pairing of all time?
Views & Analysis Medical affairs: learning to change behaviour? Research points to the need for greater engagement with behavioural science among medical affairs professionals.
Views & Analysis Face-to-face learning in a digital world Traditional ways of interacting should not be forgotten in a digital world.
Views & Analysis Horses or zebras: inspiring behavioural change to make the r... Insight into human behaviour allows development of programmes that help doctors diagnose rare diseases.
Views & Analysis New research: can pharma get healthy rewards for good behavi... Research shows industry needs to see more evidence of success for wider adoption.
Views & Analysis Behavioural science + medical education: a transformative co... ‘We need to walk in the shoes of HCPs and patients if we are to design programmes that improve health outcomes.’
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
